Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (DRKS00041166) titled 'Prospective Response Investigation by Multimodal Evaluation after Neoadjuvant Systemic Therapy prior to Radical Cystectomy (PRIME-RC)' on Sept. 1.
Study Type: observational
Study Design:
Allocation:
Masking:
Control:
Assignment:
Study design purpose: diagnostic
Primary Sponsor: Universitatsklinikum Hamburg-Eppendorf (UKE)
Condition:
C67
Malignant neoplasm of bladder
Intervention:
Group 1: Patients with histologically confirmed muscle-invasive bladder cancer (MIBC) after neoadjuvant systemic therapy and planned radical cystectomy. A standardized preoperative cystoscopy with urine cytology and cold biopsy (PE) ...